Epigallocatechin gallate, cerebral blood flow parameters, cognitive performance and mood in healthy humans: a double-blind, placebo-controlled, crossover investigation.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22389082
Conclusion of this study
These results demonstrate that a single dose of orally administered EGCG can modulate CBF parameters in healthy humans but that this is not associated with changes in cognitive performance or mood.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
||
|
||
|
Body systems related to this study
Cardiovascular System |
Nervous System |